U.S. Markets closed

Post Earnings Coverage as Analogic's Operating Metrics Improves

LONDON, UK / ACCESSWIRE / September 23, 2016 / Active Wall St. announces its post-earnings coverage on Analogic Corporation (NASDAQ: ALOG). The company released its fourth quarter fiscal 2016 (Q4 FY16) and full fiscal 2016 (FY16) financial results on September 21, 2016. The Peabody, Massachusetts-based company's revenue declined 11% y-o-y in Q4 FY16; however gross margin and non-GAAP operating margin improved by 440 and 40 basis points, respectively. Register with us now for your free membership at: http://www.activewallst.com/register/.

Today, AWS is promoting its earnings coverage on ALOG. Get our free coverage by signing up to http://www.activewallst.com/registration-3/?symbol=ALOG.

Earnings Reviewed

Analogic reported total net revenue of $138.05 million in Q4 FY16 which was below the $154.47 million recorded in the prior year's comparable quarter and market expectations of $139.03 million. The company attributed the year-over-year fall in total net revenue to delays in international Security and lower revenues in OEM probe business.

For the quarter ended July 31, 2016, GAAP net income stood at $8.77 million, or $0.70 per diluted share compared to net income of $10.87 million, or $0.86 per diluted share, in Q4 FY15. In Q4 FY16, Analogic had spent $0.07 per share on restructuring cost associated with the Restructuring Plan of 2016 announced during Q4 FY15.

The company reported non-GAAP net income of $12.77 million, or $1.02 per diluted share, Q4 FY16 versus $16.07 million, or $1.28 per diluted share, in the year-ago comparable quarter. Non-GAAP net income numbers missed analysts' estimate of $1.17 per diluted share.

For full-year FY16, the company reported consolidated revenue of $508.85 million compared to $540.29 million in FY15. Analogic's GAAP net income for FY16 came in at $12.13 million, or $0.96 per diluted share, versus $33.48 million, or $2.66 per diluted share, recorded in FY15. Additionally, the company's non-GAAP net income during FY16 was $44.73 million, or $3.54 per diluted share, compared to $51.03 million, or $4.05 per diluted share, in the year-ago comparable period.

Operating Metrics

The Medical Imaging manufacturer's gross profit came in at $63.41 million compared to $64.04 million in Q4 FY15. The company's non-GAAP gross margin improved 4.5 points in Q4 FY16, primarily on favorable mix and cost reductions across all three segments.

In FY16, the company reported gross profit of $228.07 million, marginally lower than $229.49 million in FY15. Analogic's non-GAAP gross margin was 46% for FY16, up 2.3 points y-o-y. Additionally, GAAP operating margin for FY16 stood at 5%, down 2.6 points from the year ago comparable period.


In Q4 FY16, the company's Medical Imaging segment revenue came in at $77.9 million, down 4% y-oy from $80.8 million in Q4 FY15, primarily attributed to the shipments timing of MR and mammography detector offset by growth in CT. In FY16, the segment's revenues fell marginally by 1% y-o-y to $289.2 million.

Analogic's Ultrasound segment revenue fell 4% y-o-y in Q4 FY16 to $45.6 million from $47.3 million reported in the year ago period. The company attributed this decline to the expected 58% decline in OEM probe revenues and was partially offset by strong double-digit growth in North America and China. The segment recorded revenues of $163.2 million in FY16, down 2% on y-o-y basis.

The company's Security and Detection segment revenue tumbled 45% y-o-y to $14.5 million in Q4 FY16 from $26.4 million in Q4 FY16, primarily due to lower medium-speed and high-speed system shipments. Further, the segment's revenues declined 31% y-o-y to $56.4 million in FY16.

Cash Matters & Balance Sheet

In FY16, the company reported positive cash flow from operations of $33 million which included $14.9 million as settlement for BK Medical. Analogic had cash and cash equivalents and investments worth $118.70 million at on July 31, 2016, compared to $123.80 million as on close of books in the year-ago period. Additionally, the company's long-term liabilities increased to $23.25 million on July 31, 2016, from $13.38 million recorded on July 31, 2015.


In a separate press release on September 16, 2016, the company's Board of Directors announced a quarterly cash dividend of $0.10 per each common share. The cash dividend is to be paid on October 12, 2016, to all shareholders of record on October 01, 2016.

Earnings Outlook

Analogic forecasts a mid-single digits percentage growth in revenue for full year fiscal 2017. The company is targeting non-GAAP operating margin expansion of approximately 1 point with non-GAAP earnings growth in the range of 10% to 14%. For the Medical Imaging segment, the company expects a relatively flat revenue growth for the current fiscal year. Additionally, Ultrasound segment and Security and Detection segment are expected to report double-digit growth figures.

Stock Performance

Analogic's stock is trading jumped 2.94%, closing Thursday's session at $91.95 on volume of 305.46 thousand shares. The company's shares surged 11.59% since the beginning of the year. Additionally, the stock has advanced 9.56% and 22.11% in the last three months and past six months. The company's shares are trading a PE ratio of 81.66 and have a dividend yield of 0.44%.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.


The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.


AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.


For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street